Items where Subject is "chemoresistance"
- CSHL Subject List (24)
- diseases & disorders (24)
- cancer (24)
- drugs and therapies (24)
- chemoresistance (24)
- drugs and therapies (24)
- cancer (24)
- diseases & disorders (24)
Paper
Brown, Fiona C, Cifani, Paolo, Drill, Esther, He, Jie, Still, Eric, Zhong, Shan, Balasubramanian, Sohail, Pavlick, Dean, Yilmazel, Bahar, Knapp, Kristina M, Alonzo, Todd A, Meshinchi, Soheil, Stone, Richard M, Kornblau, Steven M, Marcucci, Guido, Gamis, Alan S, Byrd, John C, Gonen, Mithat, Levine, Ross L, Kentsis, Alex (January 2017) Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia. British Journal of Haematology, 176 (1). pp. 86-91. ISSN 0007-1048
Brown, Fiona C, Still, Eric, Koche, Richard P, Yim, Christina Y, Takao, Sumiko, Cifani, Paolo, Reed, Casie, Gunasekera, Shehana, Ficarro, Scott B, Romanienko, Peter, Mark, Willie, McCarthy, Craig, de Stanchina, Elisa, Gonen, Mithat, Seshan, Venkatraman, Bhola, Patrick, O'Donnell, Conor, Spitzer, Barbara, Stutzke, Crystal, Lavallée, Vincent-Philippe, Hébert, Josée, Krivtsov, Andrei V, Melnick, Ari, Paietta, Elisabeth M, Tallman, Martin S, Letai, Anthony, Sauvageau, Guy, Pouliot, Gayle, Levine, Ross, Marto, Jarrod A, Armstrong, Scott A, Kentsis, Alex (April 2018) MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. Cancer Discovery, 8 (4). pp. 478-497. ISSN 2159-8274
Egeblad, M., Nakasone, E., Askautrud, H., Wysocki, R., Fein, M., Kees, T., Park, J., Park, J. H. (November 2014) Understanding drug responses and resistance mechanisms using imaging in live mice. Molecular Cancer Research, 12 (Supple). ISSN 1541-7786
Gao, ChongFeng, Wisniewski, Luke, Liu, Ying, Staal, Ben, Beddows, Ian, Plenker, Dennis, Aldakkak, Mohammed, Hall, Johnathan, Barnett, Daniel, Gouda, Mirna Kheir, Allen, Peter, Drake, Richard, Zureikat, Amer, Huang, Ying, Evans, Douglas, Singhi, Aatur, Brand, Randall E, Tuveson, David A, Tsai, Susan, Haab, Brian B (January 2021) Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. Clinical Cancer Research, 27 (1). pp. 226-236. ISSN 1078-0432
Ireland, L., Santos, A., Ahmed, M. S., Rainer, C., Nielsen, S. R., Quaranta, V., Weyer-Czernilofsky, U., Engle, D. D., Perez-Mancera, P., Coupland, S. E., Taktak, A. F., Bogenrieder, T., Tuveson, D. A., Campbell, F., Schmid, M. C., Mielgo, A. (December 2016) Chemoresistance in pancreatic cancer is driven by stroma-derived insulin-like growth factors. Cancer Res, 76 (23). pp. 6851-6863. ISSN 1538-7445 (Electronic)0008-5472 (Linking)
Italiano, A., Cioffi, A., Coco, P., Maki, R. G., Schoffski, P., Rutkowski, P., Le Cesne, A., Duffaud, F., Adenis, A., Isambert, N., Bompas, E., Blay, J. Y., Casali, P., Keohan, M. L., Toulmonde, M., Antonescu, C. R., Debiec-Rychter, M., Coindre, J. M., Bui, B. (May 2012) Patterns of care, prognosis, and survival in patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib. Ann Surg Oncol, 19 (5). pp. 1551-9. ISSN 1534-4681 (Electronic)1068-9265 (Linking)
Lee, H. J., Li, C. F., Ruan, D., Powers, S., Thompson, P. A., Frohman, M. A., Chan, C. H. (September 2016) The DNA Damage Transducer RNF8 Facilitates Cancer Chemoresistance and Progression through Twist Activation. Mol Cell, 63 (6). pp. 1021-33. ISSN 1097-2765
Lin, Z., Sun, L., Xie, S., Zhang, S., Fan, S., Li, Q., Chen, W., Pan, G., Wang, W., Weng, B., Zhang, Z., Liu, B., Li, J. (April 2018) Chemotherapy-Induced Long Non-coding RNA 1 Promotes Metastasis and Chemo-Resistance of TSCC via the Wnt/beta-Catenin Signaling Pathway. Mol Ther, 26 (6). pp. 1494-1508. ISSN 1525-0016
Lowe, S. W., Schmitt, C., Fridman, J., Rosenthal, C. (November 2001) Genetics of drug sensitivity and resistance in a mouse lymphoma model. Clinical Cancer Research, 7 (11). 3828S-3829S. ISSN 1078-0432
Nakasone, E., Askautrud, H., Kees, T., Park, J., Fein, M., Egeblad, M. (February 2013) Imaging contributions of the microenvironment to chemoresistance. Journal of Nuclear Medicine, 54 (Supple). p. 31. ISSN 0161-5505
Neesse, A., Krug, S., Gress, T. M., Tuveson, D. A., Michl, P. (2013) Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma. Onco Targets Ther, 7. pp. 33-43. ISSN 1178-6930 (Print)1178-6930
Rudalska, R., Dauch, D., Longerich, T., McJunkin, K., Wuestefeld, T., Kang, T. W., Hohmeyer, A., Pesic, M., Leibold, J., von Thun, A., Schirmacher, P., Zuber, J., Weiss, K. H., Powers, S., Malek, N.P., Eilers, M., Sipos, B., Lowe, S. W., Geffers, R., Laufer, S., Zender, L. (September 2014) In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer. Nature Medicine, 20 (10). pp. 1138-1146. ISSN 1078-8956
Schmitt, C. A., Fridman, J., Lowe, S. W. (July 2000) Molecular genetics of drug sensitivity and resistance in a mouse lymphoma model. British Journal of Cancer, 83. p. 4. ISSN 0007-0920
Schmitt, C. A., Lowe, S. W. (January 2001) Bcl-2 mediates chemoresistance in matched pairs of primary E mu-myc lymphomas in vivo. Blood Cells Molecules and Diseases, 27 (1). pp. 206-216. ISSN 1079-9796
Schmitt, C. A., Rosenthal, C. T., Lowe, S. W. (September 2000) Genetic analysis of chemoresistance in primary murine lymphomas. Nature Medicine, 6 (9). pp. 1029-1035. ISSN 1078-8956
Schmitt, C. A., Wallace-Brodeur, R. R., Rosenthal, C. T., McCurrach, M. E., Lowe, S. W. (2000) DNA damage responses and chemosensitivity in the E mu-myc mouse lymphoma model. Cold Spring Harbor Symposia on Quantitative Biology, 65. pp. 499-510. ISSN 0091-7451
Smolen, G. A., Sordella, R., Muir, B., Mohapatra, G., Barmettler, A., Archibald, H., Kim, W. J., Okimoto, R. A., Bell, D. W., Sgroi, D. C., Christensen, J. G., Settleman, J., Haber, D. A. (February 2006) Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proceedings of the National Academy of Sciences of the United States of America, 103 (7). pp. 2316-21. ISSN 0027-8424
Soengas, M. S., Gerald, W. L., Cordon-Cardo, C., Lazebnik, Y., Lowe, S. W. (2006) Apaf-1 expression in malignant melanoma. Cell Death and Differentiation, 13 (2). pp. 352-353. ISSN 13509047
Soengas, M. S., Lowe, S. W. (May 2003) Apoptosis and melanoma chemoresistance. Oncogene, 22 (20). pp. 3138-3151. ISSN 0950-9232
Vakoc, C. R., Garcia-Manero, G., Look, A. T. (April 2014) Cancer therapy resistance: chasing epigenetics. Nature Medicine, 20 (4). pp. 340-341. ISSN 1078-8956
Wrzeszczynski, K. O., Fan, G. F., Fu, C. X., Pappin, D. J., Lucito, R., Tonks, N. K. (April 2013) Proteomic identification of carboplatin resistance in ovarian cancer cells. Cancer Research, 73 (8 Supp). p. 2502. ISSN 0008-5472
Yin, Bin, Diers, M. D., Rathe, S. K., Lowe, S. W., Largaespada, D. A. (November 2006) Genetic mechanisms of cytarabine resistance in leukemia: cell culture and mouse transplantation models. ASH Annual Meeting Abstracts, 108 (11). p. 4374. ISSN 0006-4971
Yin, Bin, Kogan, Scott C., Dickins, Ross A., Lowe, Scott W., Largaespada, David A. (2006) Trp53 loss during in vitro selection contributes to acquired Ara-C resistance in acute myeloid leukemia. Experimental Hematology, 34 (5). pp. 631-641. ISSN 0301472X
Thesis
Rollins, F. (2011) The genetics and epigenetics of erlotinib resistance in non-small cell lung cancer. PhD thesis, Cold Spring Harbor Laboratory.